These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 1433799)

  • 1. Appearance of a methotrexate binding plasma protein during high dose methotrexate therapy.
    Iqbal MP; Malik I; Mehboobali N
    J Pak Med Assoc; 1992 Aug; 42(8):193-6. PubMed ID: 1433799
    [No Abstract]   [Full Text] [Related]  

  • 2. Mega doses of methotrexate in the treatment of osteosarcoma.
    Iqbal MP; Malik IA
    J Pak Med Assoc; 1990 Oct; 40(10):248-51. PubMed ID: 2123265
    [No Abstract]   [Full Text] [Related]  

  • 3. [The use of medium- and high-dose methotrexate in the management of malignant childhood diseases].
    Nagy K; Hunyadi K; Velkey L
    Orv Hetil; 1983 Jun; 124(24):1433-9. PubMed ID: 6576318
    [No Abstract]   [Full Text] [Related]  

  • 4. [The effect of methotrexate pharmacokinetics and of leucovorin rescue on the prognosis of osteosarcoma].
    Graf N; Jost W; Müller J; Keller HE; Sitzmann FC
    Klin Padiatr; 1990; 202(5):340-6. PubMed ID: 2214594
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical significance of non-renal elimination mechanisms of methotrexate (MTX)].
    Erttmann R; Gkanatsas A
    Monatsschr Kinderheilkd; 1985 Aug; 133(8):516-9. PubMed ID: 3876505
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A population pharmacokinetic/pharmacodynamic model of methotrexate and mucositis scores in osteosarcoma.
    Johansson ÅM; Hill N; Perisoglou M; Whelan J; Karlsson MO; Standing JF
    Ther Drug Monit; 2011 Dec; 33(6):711-8. PubMed ID: 22105588
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Methotrexate-induced bullous acral erythema in a child.
    Werchniak AE; Chaffee S; Dinulos JG
    J Am Acad Dermatol; 2005 May; 52(5 Suppl 1):S93-5. PubMed ID: 15858519
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The results of using high-dose methotrexate in treating osteogenic sarcoma].
    Perevodchikova NI; Eremina LA; Manziuk LV; Siniukov PA; Fedenko AN; Singin AS; Moldovanova LK
    Vopr Onkol; 1990; 36(6):667-71. PubMed ID: 2378085
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dose escalation with pharmacokinetics monitoring in methotrexate chemotherapy of osteosarcoma.
    Delepine N; Delepine G; Cornille H; Brion F; Arnaud P; Desbois JC
    Anticancer Res; 1995; 15(2):489-94. PubMed ID: 7763028
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacokinetic individualization of high-dose methotrexate chemotherapy for the treatment of localized osteosarcoma.
    Fujita Y; Nakamura T; Aomori T; Nishiba H; Shinozaki H; Yanagawa T; Takagishi K; Watanabe H; Okada Y; Nakamura K; Horiuchi R; Yamamoto K
    J Chemother; 2010 Jun; 22(3):186-90. PubMed ID: 20566424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Patient case involving high-dose methotrexate followed by leucovorin rescue.
    Alsop JA
    Am J Hosp Pharm; 1978 Feb; 35(2):127. PubMed ID: 305201
    [No Abstract]   [Full Text] [Related]  

  • 12. Coadministration of naproxen and low-dose methotrexate in patients with rheumatoid arthritis.
    Stewart CF; Fleming RA; Arkin CR; Evans WE
    Clin Pharmacol Ther; 1990 Apr; 47(4):540-6. PubMed ID: 2328562
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Results of chemotherapy of osteosarcoma].
    Zborzil J; Jasińska-Rubach M
    Nowotwory; 1979; Suppl():145-9. PubMed ID: 396518
    [No Abstract]   [Full Text] [Related]  

  • 14. High-dose methotrexate in fibroblastic osteosarcoma.
    Chowbay B; Siong KK
    Ann Pharmacother; 2001 Dec; 35(12):1669. PubMed ID: 11793640
    [No Abstract]   [Full Text] [Related]  

  • 15. Transient cerebral dysfunction following chemotherapy for osteogenic sarcoma.
    Allen JC; Rosen G
    Ann Neurol; 1978 May; 3(5):441-4. PubMed ID: 310278
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High-dose methotrexate in osteosarcoma: let the questions surcease--time for final acceptance.
    Jaffe N; Gorlick R
    J Clin Oncol; 2008 Sep; 26(27):4365-6. PubMed ID: 18802144
    [No Abstract]   [Full Text] [Related]  

  • 17. [Osteosarcoma of the leg; treatment results following preoperative chemotherapy].
    Postma A; Kamps WA; Schraffordt Koops H; Veth RP; Goëken LN; Oosterhuis JW; Akkerboom JC
    Ned Tijdschr Geneeskd; 1986 Mar; 130(12):545-8. PubMed ID: 3485773
    [No Abstract]   [Full Text] [Related]  

  • 18. Impact of omeprazole on the plasma clearance of methotrexate.
    Reid T; Yuen A; Catolico M; Carlson RW
    Cancer Chemother Pharmacol; 1993; 33(1):82-4. PubMed ID: 8269594
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Femur replacement.
    Staudt AR
    Am J Nurs; 1975 Aug; 75(8):1346-8. PubMed ID: 1080013
    [No Abstract]   [Full Text] [Related]  

  • 20. [Effects of hydration on plasma concentrations of methotrexate in patients with osteosarcoma treated with high doses of methotrexate].
    Ferrari S; Orlandi M; Avella M; Caldora P; Ferraro A; Ravazzolo G; Bacci G
    Minerva Med; 1992 May; 83(5):289-93. PubMed ID: 1589134
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.